Delhi HC Upholds AstraZeneca's Tagrisso Patent, Imposes Rs 7L Fine on 'Habitual Infringer' for Knockoff Production Farhat Nasim2 Dec 2024 4:48 PM ISTNew Delhi: In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical Works Ltd....
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Dapagliflozin Glimepiride Metformin FDC in Uncontrolled T2DM with HbA1c >9 % Dr Rajeev Chawla8 Oct 2024 12:24 PM ISTIntroductionIndia has the second highest rate of diabetes in the world. (1) According to the ICMR-INDIAB-17 study, the prevalence of diabetes in India...
Early Dapagliflozin Administration Cuts Heart Failure Admissions, Study Finds Dr. Prem Aggarwal3 Oct 2024 9:00 AM ISTJapan: A recent study has shed light on the effects of early versus late administration of dapagliflozin in patients suffering from decompensated...
Triple Therapy: GEMI + DAPA Enhances Glycemic Control for Type 2 Diabetics on Metformin, SOLUTION 2 study Medha Baranwal3 Oct 2024 8:00 AM ISTSouth Korea: Gemigliptin and dapagliflozin dual add-on therapy (GEMI+DAPA) along with metformin is safe, effective, and well-tolerated, particularly...
Eris Lifscience Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin29 Sept 2024 6:00 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) antidiabetic drug Dapagliflozin Propanediol Monohydrate...
Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study Dr. Divya Colin25 Sept 2024 6:00 PM ISTNew Delhi: Noting the proposed fixed-dose combination (FDC) of 24 mg extended-release (ER) Torsemide and 8 mg Dapagliflozin Tablets is not rational;...
Neuropathy Impact on Outcomes and Efficacy in HF Patients with Type 2 Diabetes: Insights from DAPA-HF and DELIVER Trials Dr.Niharika Harsha B23 Sept 2024 8:45 AM ISTNew research found that Dapagliflozin reduces the relative and absolute risk of death and heart failure-related hospitalization due to diabetic...
Dapagliflozin Enhances Glycemic Control When Added to Evogliptin and Metformin in Type 2 Diabetes Patients: Study Medha Baranwal13 Sept 2024 9:45 AM ISTKorea: A recent randomized, double-blind, placebo-controlled study has revealed promising results for adding dapagliflozin to an existing regimen of...
Micro Labs Launches Linapride DM: Affordable Diabetes Treatment in India MD Brand Connect2 Sept 2024 12:48 PM ISTUncontrolled Diabetes has become a major challenge in today's Diabetes Management and it keeps raising the bar. As per the ICMR-INDIAB Study...
Breakthrough combo therapy for type 1 diabetes: SGLT2 inhibitors + GRAs boost control, cut insulin use, study reveals Medha Baranwal20 Aug 2024 8:30 AM ISTUSA: In a significant development for treating Type 1 diabetes (T1D), researchers have conducted a randomized clinical trial testing a combination...
Dapagliflozin Enhances Right Ventricular Function in Heart Failure Patients, shows study Medha Baranwal27 July 2024 9:30 AM ISTUSA: Dapagliflozin enhances right ventricular pulsatile afterload and myocardial performance during exercise, which correlates with a reduction in...
